|
Reference
1. Ferrari, M., Cancer nanotechnology: opportunities and challenges. Nature reviews cancer, 2005. 5(3): p. 161. 2. Koo, O.M., I. Rubinstein, and H. Onyuksel, Role of nanotechnology in targeted drug delivery and imaging: a concise review. Nanomedicine: Nanotechnology, Biology and Medicine, 2005. 1(3): p. 193-212. 3. Car, A., et al., pH-Responsive PDMS-b-PDMAEMA Micelles for Intracellular Anticancer Drug Delivery. Biomacromolecules, 2014. 15(9): p. 3235-3245. 4. Tomlinson, R., et al., Polyacetal− doxorubicin conjugates designed for ph-dependent degradation. Bioconjugate chemistry, 2003. 14(6): p. 1096-1106. 5. Ge, Z. and S. Liu, Functional block copolymer assemblies responsive to tumor and intracellular microenvironments for site-specific drug delivery and enhanced imaging performance. Chemical Society Reviews, 2013. 42(17): p. 7289-7325. 6. Lee, S.H., et al., Current Progress in Reactive Oxygen Species (ROS)‐Responsive Materials for Biomedical Applications. Advanced healthcare materials, 2013. 2(6): p. 908-915. 7. Li, Z.-Y., et al., A redox-responsive drug delivery system based on RGD containing peptide-capped mesoporous silica nanoparticles. Journal of Materials Chemistry B, 2015. 3(1): p. 39-44. 8. Huang, X., et al., Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. Journal of the American Chemical Society, 2006. 128(6): p. 2115-2120. 9. Yuan, H., A.M. Fales, and T. Vo-Dinh, TAT peptide-functionalized gold nanostars: enhanced intracellular delivery and efficient NIR photothermal therapy using ultralow irradiance. Journal of the American Chemical Society, 2012. 134(28): p. 11358-11361. 10. Kawano, T., et al., PNIPAM gel-coated gold nanorods for targeted delivery responding to a near-infrared laser. Bioconjugate chemistry, 2009. 20(2): p. 209-212. 11. Shi, J., et al., A tumor-targeting near-infrared laser-triggered drug delivery system based on GO@ Ag nanoparticles for chemo-photothermal therapy and X-ray imaging. Biomaterials, 2014. 35(22): p. 5847-5861. 12. Cho, H.J., M. Chung, and M.S. Shim, Engineered photo-responsive materials for near-infrared-triggered drug delivery. Journal of Industrial and Engineering Chemistry, 2015. 31: p. 15-25. 13. Peer, D., et al., Nanocarriers as an emerging platform for cancer therapy. Nature nanotechnology, 2007. 2(12): p. 751. 14. Sharma, A. and U.S. Sharma, Liposomes in drug delivery: progress and limitations. International journal of pharmaceutics, 1997. 154(2): p. 123-140. 15. Trédan, O., et al., Drug resistance and the solid tumor microenvironment. Journal of the National Cancer Institute, 2007. 99(19): p. 1441-1454. 16. Zhang, L., et al., A multifunctional platform for tumor angiogenesis-targeted chemo-thermal therapy using polydopamine-coated gold nanorods. ACS nano, 2016. 10(11): p. 10404-10417. 17. Wang, X., et al., Multi-responsive photothermal-chemotherapy with drug-loaded melanin-like nanoparticles for synergetic tumor ablation. Biomaterials, 2016. 81: p. 114-124. 18. Weis, S.M. and D.A. Cheresh, Tumor angiogenesis: molecular pathways and therapeutic targets. Nature medicine, 2011. 17(11): p. 1359. 19. Ellis, L.M. and D.J. Hicklin, VEGF-targeted therapy: mechanisms of anti-tumour activity. Nature reviews cancer, 2008. 8(8): p. 579. 20. Folkman, J., Tumor angiogenesis: therapeutic implications. New england journal of medicine, 1971. 285(21): p. 1182-1186. 21. Yu, D.-H., et al., IF7-Conjugated nanoparticles target annexin 1 of tumor vasculature against P-gp mediated multidrug resistance. Bioconjugate chemistry, 2015. 26(8): p. 1702-1712. 22. Takahashi, H. and M. Shibuya, The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions. Clinical science, 2005. 109(3): p. 227-241. 23. Fukumura, D. and R.K. Jain, Tumor microvasculature and microenvironment: targets for anti-angiogenesis and normalization. Microvascular research, 2007. 74(2-3): p. 72-84. 24. Bartczak, D., et al., Manipulation of in vitro angiogenesis using peptide-coated gold nanoparticles. Acs Nano, 2013. 7(6): p. 5628-5636. 25. Mukherjee, P., et al., Antiangiogenic properties of gold nanoparticles. Clinical Cancer Research, 2005. 11(9): p. 3530-3534. 26. Lai, P.-X., et al., Ultrastrong trapping of VEGF by graphene oxide: anti-angiogenesis application. Biomaterials, 2016. 109: p. 12-22. 27. Day, E.S., et al., Vascular-targeted photothermal therapy of an orthotopic murine glioma model. Nanomedicine, 2012. 7(8): p. 1133-1148. 28. Shi, S., et al., VEGFR targeting leads to significantly enhanced tumor uptake of nanographene oxide in vivo. Biomaterials, 2015. 39: p. 39-46. 29. Lv, L., et al., Enhanced antiglioblastoma efficacy of neovasculature and glioma cells dual targeted nanoparticles. Molecular pharmaceutics, 2016. 13(10): p. 3506-3517. 30. Dahmani, F.Z., et al., Multifunctional Polymeric Nanosystems for Dual‐Targeted Combinatorial Chemo/Antiangiogenesis Therapy of Tumors. Advanced healthcare materials, 2016. 5(12): p. 1447-1461. 31. Yao, J., et al., Neovasculature and circulating tumor cells dual-targeting nanoparticles for the treatment of the highly-invasive breast cancer. Biomaterials, 2017. 113: p. 1-17. 32. Chen, D., et al., Dual targeting luminescent gold nanoclusters for tumor imaging and deep tissue therapy. Biomaterials, 2016. 100: p. 1-16. 33. Li, X., et al., Tumor vascular-targeted co-delivery of anti-angiogenesis and chemotherapeutic agents by mesoporous silica nanoparticle-based drug delivery system for synergetic therapy of tumor. International journal of nanomedicine, 2016. 11: p. 93. 34. Xu, B., et al., Combined tumor-and neovascular-“dual targeting” gene/chemo-therapy suppresses tumor growth and angiogenesis. ACS applied materials & interfaces, 2016. 8(39): p. 25753-25769. 35. Yuan, H., et al., Gold nanostars: surfactant-free synthesis, 3D modelling, and two-photon photoluminescence imaging. Nanotechnology, 2012. 23(7): p. 075102. 36. Xie, J., J.Y. Lee, and D.I. Wang, Seedless, surfactantless, high-yield synthesis of branched gold nanocrystals in HEPES buffer solution. Chemistry of materials, 2007. 19(11): p. 2823-2830. 37. Hao, F., et al., Plasmon resonances of a gold nanostar. Nano letters, 2007. 7(3): p. 729-732. 38. Link, S. and M.A. El-Sayed, Shape and size dependence of radiative, non-radiative and photothermal properties of gold nanocrystals. International reviews in physical chemistry, 2000. 19(3): p. 409-453. 39. Chirico, G., M. Borzenkov, and P. Pallavicini, Gold nanostars: synthesis, properties and biomedical application. 2015: Springer. 40. Hong, S., et al., Non‐covalent self‐assembly and covalent polymerization co‐contribute to polydopamine formation. Advanced Functional Materials, 2012. 22(22): p. 4711-4717. 41. Liu, Y., K. Ai, and L. Lu, Polydopamine and its derivative materials: synthesis and promising applications in energy, environmental, and biomedical fields. Chemical reviews, 2014. 114(9): p. 5057-5115. 42. Miao, Z.-H., et al., Intrinsically Mn2+-chelated polydopamine nanoparticles for simultaneous magnetic resonance imaging and photothermal ablation of cancer cells. ACS applied materials & interfaces, 2015. 7(31): p. 16946-16952. 43. Tao, W., et al., Polydopamine-based surface modification of novel nanoparticle-aptamer bioconjugates for in vivo breast cancer targeting and enhanced therapeutic effects. Theranostics, 2016. 6(4): p. 470. 44. Zhuang, H., et al., Polydopamine Nanocapsule: A Theranostic Agent for Photoacoustic Imaging and Chemo-Photothermal Synergistic Therapy. ACS Biomaterials Science & Engineering, 2017. 3(8): p. 1799-1808. 45. Jin, Z. and H. Fan, The modulation of melanin‐like materials: methods, characterization and applications. Polymer International, 2016. 65(11): p. 1258-1266. 46. Mrówczyński, R., Polydopamine-based multifunctional (nano) materials for cancer therapy. ACS applied materials & interfaces, 2017. 10(9): p. 7541-7561. 47. Kumar, A., et al., Oxidative nanopeeling chemistry-based synthesis and photodynamic and photothermal therapeutic applications of plasmonic core-petal nanostructures. Journal of the American Chemical Society, 2014. 136(46): p. 16317-16325. 48. Wang, S., et al., Biologically inspired polydopamine capped gold nanorods for drug delivery and light-mediated cancer therapy. ACS applied materials & interfaces, 2016. 8(37): p. 24368-24384. 49. Yu, Y., et al., Ultrasmall dopamine-coated nanogolds: preparation, characteristics, and CT imaging. Journal of experimental nanoscience, 2016. 11(sup1): p. S1-S11. 50. Zeng, Y., et al., Lipid-AuNPs@ PDA nanohybrid for MRI/CT imaging and photothermal therapy of hepatocellular carcinoma. ACS applied materials & interfaces, 2014. 6(16): p. 14266-14277. 51. Wang, F., et al., Polydopamine‐Functionalized Graphene Oxide Loaded with Gold Nanostars and Doxorubicin for Combined Photothermal and Chemotherapy of Metastatic Breast Cancer. Advanced healthcare materials, 2016. 5(17): p. 2227-2236. 52. Black, K.C., et al., Polydopamine-enabled surface functionalization of gold nanorods for cancer cell-targeted imaging and photothermal therapy. Nanomedicine, 2013. 8(1): p. 17-28. 53. Li, D., et al., Construction of polydopamine-coated gold nanostars for CT imaging and enhanced photothermal therapy of tumors: an innovative theranostic strategy. Journal of Materials Chemistry B, 2016. 4(23): p. 4216-4226. 54. Du, B., et al., Hybrid of gold nanostar and indocyanine green for targeted imaging-guided diagnosis and phototherapy using low-density laser irradiation. Journal of Materials Chemistry B, 2016. 4(35): p. 5842-5849. 55. Li, C., Z. Liu, and P. Yao, Gold nanoparticles coated with a polydopamine layer and dextran brush surface for diagnosis and highly efficient photothermal therapy of tumors. RSC Advances, 2016. 6(39): p. 33083-33091. 56. Tian, Y., et al., Mussel‐Inspired Gold Hollow Superparticles for Photothermal Therapy. Advanced healthcare materials, 2015. 4(7): p. 1009-1014. 57. de Puig, H., et al., Extinction coefficient of gold nanostars. The Journal of Physical Chemistry C, 2015. 119(30): p. 17408-17415. 58. Cheng, W., et al., pH-Sensitive delivery vehicle based on folic acid-conjugated polydopamine-modified mesoporous silica nanoparticles for targeted cancer therapy. ACS applied materials & interfaces, 2017. 9(22): p. 18462-18473. 59. Gref, R., et al., The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. Advanced drug delivery reviews, 1995. 16(2-3): p. 215-233. 60. Dam, D.H.M., R.C. Lee, and T.W. Odom, Improved in vitro efficacy of gold nanoconstructs by increased loading of G-quadruplex aptamer. Nano letters, 2014. 14(5): p. 2843-2848. 61. Liu, X., et al., Mussel-inspired polydopamine: a biocompatible and ultrastable coating for nanoparticles in vivo. ACS nano, 2013. 7(10): p. 9384-9395. 62. Nam, J., et al., Chemo-photothermal therapy combination elicits anti-tumor immunity against advanced metastatic cancer. Nature communications, 2018. 9(1): p. 1074. 63. Liu, Q., et al., Highly selective uptake and release of charged molecules by pH‐responsive polydopamine microcapsules. Macromolecular bioscience, 2011. 11(9): p. 1227-1234. 64. Maruyama, K., Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects. Advanced drug delivery reviews, 2011. 63(3): p. 161-169. 65. Poinard, B., et al., Polydopamine Nanoparticles Enhances Drug Release for Combined Photodynamic and Photothermal Therapy. ACS applied materials & interfaces, 2018. 66. Della Vecchia, N.F., et al., Building‐block diversity in polydopamine underpins a multifunctional eumelanin‐type platform tunable through a quinone control point. Advanced Functional Materials, 2013. 23(10): p. 1331-1340. 67. Liu, F., et al., Facile Preparation of Doxorubicin‐Loaded Upconversion@ Polydopamine Nanoplatforms for Simultaneous In Vivo Multimodality Imaging and Chemophotothermal Synergistic Therapy. Advanced healthcare materials, 2015. 4(4): p. 559-568. 68. Dong, Z., et al., Polydopamine nanoparticles as a versatile molecular loading platform to enable imaging-guided cancer combination therapy. Theranostics, 2016. 6(7): p. 1031. 69. Wang, X., et al., A polydopamine nanoparticle-knotted poly (ethylene glycol) hydrogel for on-demand drug delivery and chemo-photothermal therapy. Chemistry of Materials, 2017. 29(3): p. 1370-1376. 70. Cui, J., et al., Immobilization and intracellular delivery of an anticancer drug using mussel-inspired polydopamine capsules. Biomacromolecules, 2012. 13(8): p. 2225-2228. 71. Zhang, R., et al., Smart micelle@ polydopamine core–shell nanoparticles for highly effective chemo–photothermal combination therapy. Nanoscale, 2015. 7(46): p. 19722-19731. 72. Wei, Y., et al., Polydopamine and peptide decorated doxorubicin-loaded mesoporous silica nanoparticles as a targeted drug delivery system for bladder cancer therapy. Drug delivery, 2017. 24(1): p. 681-691. 73. Ochs, C.J., et al., Dopamine-mediated continuous assembly of biodegradable capsules. Chemistry of Materials, 2011. 23(13): p. 3141-3143. 74. Belitsky, J.M., et al., Small molecule modulators of aggregation in synthetic melanin polymerizations. Bioorganic & medicinal chemistry letters, 2012. 22(17): p. 5503-5507. 75. Zhong, X., et al., Polydopamine as a biocompatible multifunctional nanocarrier for combined radioisotope therapy and chemotherapy of cancer. Advanced Functional Materials, 2015. 25(47): p. 7327-7336. 76. Li, Y., et al., Targeted polydopamine nanoparticles enable photoacoustic imaging guided chemo-photothermal synergistic therapy of tumor. Acta biomaterialia, 2017. 47: p. 124-134. 77. Jordans, S., et al., Monitoring compartment-specific substrate cleavage by cathepsins B, K, L, and S at physiological pH and redox conditions. BMC biochemistry, 2009. 10(1): p. 23. 78. Xing, Y., et al., Mesoporous polydopamine nanoparticles with co-delivery function for overcoming multidrug resistance via synergistic chemo-photothermal therapy. Nanoscale, 2017. 9(25): p. 8781-8790. 79. Kusano, R., et al., α-Amylase and lipase inhibitory activity and structural characterization of acacia bark proanthocyanidins. Journal of natural products, 2010. 74(2): p. 119-128. 80. Jeong, Y., et al., Sprayable Adhesive Nanotherapeutics: Mussel Protein-Based Nanoparticles for Highly Efficient Locoregional Cancer Therapy. ACS nano, 2018. 81. Fu, X., et al., IONP-doped nanoparticles for highly effective NIR-controlled drug release and combination tumor therapy. International journal of nanomedicine, 2017. 12: p. 3751. 82. Pan, J. and S.-S. Feng, Targeting and imaging cancer cells by folate-decorated, quantum dots (QDs)-loaded nanoparticles of biodegradable polymers. Biomaterials, 2009. 30(6): p. 1176-1183. 83. Kang, M.J., et al., Folic acid-tethered Pep-1 peptide-conjugated liposomal nanocarrier for enhanced intracellular drug delivery to cancer cells: conformational characterization and in vitro cellular uptake evaluation. International journal of nanomedicine, 2013. 8: p. 1155. 84. Yang, K.K., et al., Folate-modified–chitosan-coated liposomes for tumor-targeted drug delivery. Journal of Materials Science, 2013. 48(4): p. 1717-1728. 85. Hasanpourghadi, M., et al., Mechanisms of the anti-tumor activity of Methyl 2-(-5-fluoro-2-hydroxyphenyl)-1 H-benzo [d] imidazole-5-carboxylate against breast cancer in vitro and in vivo. Oncotarget, 2017. 8(17): p. 28840. 86. Tomankova, K., et al., In vitro cytotoxicity analysis of doxorubicin-loaded/superparamagnetic iron oxide colloidal nanoassemblies on MCF7 and NIH3T3 cell lines. International journal of nanomedicine, 2015. 10: p. 949. 87. Dang, Y., et al., Substrate independent coating formation and anti-biofouling performance improvement of mussel inspired polydopamine. Journal of materials chemistry B, 2015. 3(20): p. 4181-4190. 88. Zaccaria, A., et al., Accessing to the minor proteome of red blood cells through the influence of the nanoparticle surface properties on the corona composition. International journal of nanomedicine, 2015. 10: p. 1869.
|